3 news items
Actinium Pharmaceuticals (ATNM) Reveals Promising Results from SIERRA Trial at EHA Congress
ATNM
BMRN
EXEL
17 Jun 24
. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor regarding forward-looking statements. Any statement that projects
MAIA Biotechnology (MAIA): Pioneering New Frontiers in NSCLC Treatment with THIO
BMRN
EXEL
GMAB
7 Jun 24
adviser. The content here is purely informational and should not be taken as investment advice. The Private Securities Litigation Reform Act of 1995
Ligand Reports First Quarter 2024 Financial Results
AMGN
CASI
JAZZ
7 May 24
litigation could expose Ligand to significant liabilities and have a material adverse effect on the company. The failure to meet expectations
- Prev
- 1
- Next